title: Balancing the risks and benefits of dual platelet inhibition.
authors.affiliation: From the Division of Cardiovascular Medicine, University of Massachusetts Medical School, Worcester.
authors.forename: John F
authors.initials: JF
authors.lastname: Keaney
mesh_terms: D000241:Adenosine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D001241:Aspirin / Q000008:administration & dosage*; D054855:Drug-Eluting Stents; D005260:Female; D006801:Humans; D008297:Male; D010879:Piperazines / Q000008:administration & dosage*; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*; D013876:Thiophenes / Q000008:administration & dosage*; D013927:Thrombosis / Q000517:prevention & control*; D000077486:Ticagrelor; D013988:Ticlopidine / Q000031:analogs & derivatives*
chemical_list: D010879:Piperazines; D010975:Platelet Aggregation Inhibitors; D013876:Thiophenes; D000077486:Ticagrelor; D000241:Adenosine; D013988:Ticlopidine; D001241:Aspirin